You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫藥行業喜事連連 港A兩地藥品股普漲
格隆匯 11-07 11:15
格隆匯11月7日丨醫藥行業近日喜事連連,先是上週末公佈一款(971)治療阿爾茨海默症新藥已通過國家藥品監督管理局批准,港A市場沾邊的概念股大漲;再是昨天港股長江生命科技(0775.HK)公佈了自己“黑色素瘤抗原疫苗免疫療法研究的初始數據喜人”的消息,該股昨天暴漲超150%,今日繼續漲近30%。同時,兩件大利好的宣佈也帶動了港A兩地整個醫藥板塊的上漲。港股市場除長江生命科技目前漲近30%外,復星醫藥漲近6%,億勝生物科技、石藥集團、李氏大藥廠漲幅均在3%以上。A股市場上,復星醫藥漲近6%,四環生物漲近5%,上海萊士、通化東寶和安科生物漲超3%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account